Loomis, Sayles & Company’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,872,070
| Closed | -$30M | – | 945 |
|
|
2021
Q2 | $30M | Sell |
1,872,070
-38,030
| -2% | -$609K | 0.04% | 251 |
|
|
2021
Q1 | $34.1M | Sell |
1,910,100
-6,143
| -0.3% | -$110K | 0.04% | 210 |
|
|
2020
Q4 | $25.9M | Sell |
1,916,243
-10,948
| -0.6% | -$148K | 0.03% | 230 |
|
|
2020
Q3 | $22.7M | Buy |
1,927,191
+745,413
| +63% | +$8.77M | 0.03% | 210 |
|
|
2020
Q2 | $17.4M | Buy |
+1,181,778
| New | +$17.4M | 0.03% | 242 |
|
|
2018
Q4 | – | Sell |
-371,215
| Closed | -$22.8M | – | 964 |
|
|
2018
Q3 | $22.8M | Buy |
371,215
+67,871
| +22% | +$4.18M | 0.04% | 195 |
|
|
2018
Q2 | $20.5M | Buy |
303,344
+35,672
| +13% | +$2.41M | 0.04% | 241 |
|
|
2018
Q1 | $14.5M | Sell |
267,672
-9,058
| -3% | -$491K | 0.03% | 329 |
|
|
2017
Q4 | $16.5M | Sell |
276,730
-1,479
| -0.5% | -$88.4K | 0.03% | 318 |
|
|
2017
Q3 | $13.5M | Buy |
+278,209
| New | +$13.5M | 0.03% | 359 |
|